Company: BWAY
Filing Date: 2025-05-01
Form Type: 424B3
Source: 0001171843-25-002668
Chunk: 9

Company: Brainsway Ltd.
Filing Date: 2025-05-01
Form: 424B3
Chunk 9
---
 in our securities involves a high degree
of risk. Our business, financial condition or results of operations could be adversely affected by any of these risks. You should carefully
consider the risk factors discussed below and under the caption “Item 3: Key Information -Risk Factors”
in our Annual Report on Form 20-F for the year ended December 31, 2024, and in any other filings we make with the SEC subsequent to the
date of this prospectus, each of which are incorporated herein by reference, and in any supplement to this prospectus or free writing
prospectus, before making your investment decision. The risks and uncertainties we have described are not the only ones we face. Additional
risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. Past financial
performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends
in future periods. If any of these risks actually occurs, our business, business prospects, financial condition or results of operations
could be seriously harmed. This could cause the trading price of our Ordinary Shares (directly or in the form of ADSs) to decline, resulting
in a loss of all or part of your investment. Please also read carefully the section below entitled “Forward-Looking Statements.”

Sales of the ADSs or Ordinary Shares by the selling shareholder, or the perception that they may occur, could cause the market price of the ADSs or Ordinary Shares to decline.

As of March 31, 2025, the selling shareholder, which
represents our largest shareholder, beneficially owned through its ownership of the Offered ADSs 17.69% of our outstanding Ordinary Shares.
We cannot predict if and when the selling shareholder may sell such securities in the public market.

The resale of all or a substantial portion of such
ADSs and/or underlying Ordinary Shares held by the selling shareholder in the public market, or the perception that these sales might
occur, could cause the market price of the ADSs on the Nasdaq Global Market and the Ordinary Shares on the TASE, respectively, to decline
or become more volatile, and could make it more difficult for us to sell our share capital in the future at a time and upon terms that
we deem appropriate. Further, any exercise of the Warrant by the selling shareholder into ADSs would dilute the current holders of our
securities.

<div align='center'>FORWARD-LOOKING